nanoTox Inc., the only
company to provide complete risk assessment exclusively for nanoparticles, announced
today that its Chief Scientific Officer, Dr. David Hobson, will be a panelist
at the 8th Annual Nanotechnology and Sustainability Venture Forum. The forum
will be held at Rice University in Houston, Texas, on February 12, 2009.
One of the world’s foremost toxicological experts on the commercialization
and development of safe nanotechnologies, Dr. Hobson will speak on Nano Environmental
Health and Safety.
"As companies employ nanoparticles in their processes and products, making
sure that the public and our environment are safe from unintended effects is
a valid and necessary concern," stated Dr. Hobson. "With proper analysis
and applied solutions, however, we can mitigate, manage and even eliminate risks
that may be associated with these particles and enjoy the many benefits nanotechnology
Dr. Hobson has 30 years of practical experience in toxicologic research and
development including environmental, industrial, and medical projects for government,
industry and private concerns. His experience with nanomaterials includes pharmacological
and toxicological research using in vitro and in vivo pre-clinical models; preparation
of medical device submissions to regulatory agencies, as well as chemistry and
manufacturing controls and pharmacology/toxicology sections for new drug applications.
His work with nanoTox Inc. involves the establishment of state-of-the-art facilities
and test procedures that are conducted for clients under strict confidentiality
and in accordance with established U.S. good laboratory practices and international
data quality standards.
Dr. Hobson is a noted consultant to government and industry on product and
technology development issues for dermatologic, wound healing and tissue repair
therapeutics. He also is a past president of the American College of Toxicology
and an editorial advisor to the International Journal of Toxicology. At the
University of the Incarnate Word in San Antonio, he teaches courses in biophysics,
nuclear pharmacy, immunoassay and radiation biology.
Dr. Hobson has many scientific publications to his credit including the book
Dermal and Ocular Toxicology: Fundamentals and Methods; and book chapters on
product risk assessment, toxicology study design, toxicology of wound healing,
dermal toxicology and gastrointestinal toxicology. He has led successful projects
including all aspects of pharmaceutical development – from discovery,
development and registration to post-market support – which have resulted
in currently marketed pharmaceutical products and numerous patents.